UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000061727
Receipt number R000070213
Scientific Title Acute Effects of Cupping Applied to the Lower Leg on Ankle Dorsiflexion Range of Motion and Muscle-Fascial Stiffness
Date of disclosure of the study information 2026/05/29
Last modified on 2026/05/29 13:45:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Acute Effects of Cupping Applied to the Lower Leg on Ankle Dorsiflexion Range of Motion and Muscle-Fascial Stiffness

Acronym

Acute Effects of Cupping Applied to the Lower Leg on Ankle Dorsiflexion Range of Motion and Muscle-Fascial Stiffness

Scientific Title

Acute Effects of Cupping Applied to the Lower Leg on Ankle Dorsiflexion Range of Motion and Muscle-Fascial Stiffness

Scientific Title:Acronym

Cupping Effects on Lower Leg Musculofascial Properties

Region

Japan


Condition

Condition

Muscle and fascial stiffness and ankle dorsiflexion range of motion in healthy adults

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the acute effects of cupping applied to the posterior lower leg on muscle and fascial stiffness, ankle dorsiflexion range of motion, and lower leg muscle activity during passive dorsiflexion in healthy adults

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Ankle dorsiflexion range of motion measured immediately after intervention (0 min post-intervention) using an isokinetic dynamometer (unit: degrees)

Key secondary outcomes

Shear modulus of the superficial fascia,superficial,middle and deep portions of the medial gastrocnemius and deep intermuscular fascia measured immediately after intervention using shear wave elastography. Muscle activity of the tibialis anterior,medial gastrocnemius,and soleus during passive ankle dorsiflexion measured immediately after intervention using surface electromyography.


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Moving cupping applied to the posterior lower leg using a silicone cup. With the participant in the prone position, lotion was applied to the skin surface, and the cup was manually compressed to generate negative pressure and repeatedly slid in a proximal-to-distal direction along the muscle fiber orientation of the medial gastrocnemius. Duration: 1 minute per session; frequency: once per condition.

Interventions/Control_2

Five minutes of supine rest without any cupping intervention, serving as a control condition to account for the effect of time passage. No intervention applied; performed once per condition.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

30 years-old >

Gender

Male and Female

Key inclusion criteria

Healthy university or graduate school students
Aged 18 years or older and under 30 years
No history of orthopedic injury in the lower limb (muscle, tendon, joint capsule, or ligament injury; peripheral neuropathy)
No neurological abnormality
Ability to understand the study content and provide written informed consent

Key exclusion criteria

History of orthopedic injury in the lower limb
Neurological disorders
Skin disease, skin hypersensitivity, or open wound at the intervention site
Blood coagulation disorder or use of anticoagulant medication
Pain at the measurement or intervention site
Inability or unwillingness to provide informed consent

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Toshihiro
Middle name
Last name Maemichi

Organization

Waseda University

Division name

Faculty of Sport Sciences

Zip code

359-1192

Address

Mikajima 2-579-15, Tokorozawa, Saitama 359-1192, Japan

TEL

080-1090-3238

Email

t.maemichi@aoni.waseda.jp


Public contact

Name of contact person

1st name Toshihiro
Middle name
Last name Maemichi

Organization

Waseda University

Division name

Faculty of Sport Sciences

Zip code

359-1192

Address

Mikajima 2-579-15, Tokorozawa, Saitama 359-1192, Japan

TEL

080-1090-3238

Homepage URL


Email

t.maemichi@aoni.waseda.jp


Sponsor or person

Institute

Waseda University

Institute

Department

Personal name

Toshihiro Maemichi


Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Review Committee on Research Involving Human Subjects, Waseda University

Address

Mikajima 2-579-15, Tokorozawa, Saitama, Japan

Tel

03-5272-1639

Email

rinri@list.waseda.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 05 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 12 Month 31 Day

Date of IRB


Anticipated trial start date

2026 Year 05 Month 29 Day

Last follow-up date

2026 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 05 Month 29 Day

Last modified on

2026 Year 05 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000070213